Hypophysectomy and adrenalectomy for disseminated prostatic carcinoma.

No abstract is available for this paper.

• Publication year

  1971

• Venue

  Journal of Urology

• Publication date

  1971-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0022-5347(17)61638-0PMID 4103890
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Erythropoietin release in hypophysectomized, adrenalectomized man

  1970cited by this paper
• Hypophysectomy for disseminated prostatic carcinoma

  1969cited by this paper
• Measurement of human luteinizing hormone in plasma by radioimmunoassay.

  1968cited by this paper
• Steroid hormone metabolites before and after orchiectomy for prostatic cancer.

  1963cited by this paper
• Hypoglycemia: A Potent Stimulus to Secretion of Growth Hormone

  1963cited by this paper
• Separation of urinary 17-ketosteroids by gas chromatography.

  1961cited by this paper
• Some inferences from hypophysectomy on four hundred fifty human patients.

  1960cited by this paper
• The neurosurgeon's new interest in the pituitary.

  1960cited by this paper
• Hypophysectomy in the treatment of metastatic mammary cancer.

  1960cited by this paper
• The effect of hypophysectomy in advanced carcinoma of the prostate.

  1959cited by this paper
• The effect of cortisone and cortisol on 17‐ketosteroid excretion in carcinoma of the prostate and other neoplasms

  1959cited by this paper
• The conversion of cortisone to 17-ketosteroids in patients with carcinoma of the prostate and of the lung.

  1959cited by this paper
• Hypophysectomy in the treatment of malignant tumors

  1957cited by this paper
• Hypophysectomy in treatment of advanced cancer.

  1956cited by this paper
• Hormone therapy in prostatic cancer.

  1956cited by this paper
• The role of the adrenal cortex in prostatic cancer.

  1955cited by this paper
• Hypophysectomy in the treatment of advanced cancer.

  1955cited by this paper
• Effect of Cortisone on 17-Ketosteroid Excretion *

  1954cited by this paper
• Role of pituitary in normal and abnormal prostatic growth.

  1954cited by this paper
• Effect of cortisone on patients with carcinoma of prostate.

  1954cited by this paper
• Effect of adrenocortical steroids on androgen excretion by adrenalectomized orchidectomized men.

  1954cited by this paper
• Appraisal of present methods of treatment of advanced prostatic cancer.

  1954cited by this paper
• Role of pituitary in normal and abnormal prostatic growth.

  1954cited by this paper
• Total adrenalectomy for reactivated carcinoma of the prostate.

  1953cited by this paper
• Clinical and metabolic studies of bilateral adrenalectomy for advanced cancer in man.

  1953cited by this paper
• Metabolic studies on the bilateral adrenalectomy patient.

  1953cited by this paper
• Bilateral adrenalectomy for prostatic cancer.

  1952cited by this paper
• Endocrine management of disseminated prostatic cancer, including bilateral adrenalectomy and hypophysectomy.

  1952cited by this paper
• Endocrine management of disseminated prostatic cancer, including bilateral adrenalectomy and hypophysectomy.

  1952cited by this paper
• Pituitary irradiation in prostatic carcinoma.

  1951cited by this paper
• Bilateral Adrenalectomy in Prostatic Cancer: Clinical Features and Urinary Excretion of 17-Ketosteroids and Estrogen.

  1945cited by this paper
• Bilateral adrenalectomy in prostatic cancer.

  1945cited by this paper
• Studies on Prostatic Cancer. V. Excretion of 17-Ketosteroids, Estrogens and Gonadotropins before and after Castration1

  1942cited by this paper

• Orchidectomy as a Method of Immunopotentiation in Mice

  2008cites this paper
• Effect of combination therapy with aminoglutethimide and hydrocortisone on prostate-specific antigen response in metastatic prostate cancer refractory to standard endocrine therapy

  2004cites this paper
• Effect of combination therapy with aminoglutethimide and hydrocortisone on prostate-specific antigen response in metastatic prostate cancer refractory to standard endocrine therapy

  2004cites this paper
• A phase I study of the somatostatin analogue somatuline in patients with metastatic hormone‐refractory prostate cancer

  1995cites this paper
• Treatment of advanced prostate cancer.

  1989cites this paper
• Hormonal Therapy of Prostate Cancer: Limitations in the Total Androgen Ablation Concept

  1988cites this paper
• Flutamide and other antiandrogens in the treatment of advanced prostatic carcinoma.

  1988cites this paper
• The influence of castration on the development of prostatic carcinoma in the dog. 43 cases (1978-1985).

  1987cites this paper
• Treatment of advanced prostatic cancer.

  1987cites this paper
• Objective responses to ketoconazole therapy in patients with relapsed progressive prostatic cancer.

  1986cites this paper
• Evaluation of aminoglutethimide in stage D prostate cancer: an assessment of efficacy and toxicity in patients with tumors refractory to hormonal therapy.

  1984cites this paper
• Combined transethmoidal rhinoseptal approach to the spheno-seller area

  1984cites this paper
• Orchiectomy does not selectively increase adrenal androgen concentrations.

  1984cites this paper
• Transphenoidal hypophysectomy in the management of carcinoma of the prostate

  1984cites this paper
• Medical Management of Chronic Pain Caused by Cancer

  1983cites this paper
• A phase II study Nolvadex: tamoxifen citrate in the treatment of advanced prostatic adenocarcinoma.

  1982cites this paper
• Quantitative Physiopathology of Prostatic Carcinoma

  1981cites this paper
• Endocrine Aspects and Steroid Receptors in Prostatic Carcinoma

  1981cites this paper
• Overview of past and current philosophy of prostatic cancer

  1980cites this paper
• Pituitary ablation in the relief of pain in advanced prostatic carcinoma.

  1980cites this paper
• Clinical Utilization of Alkaline Phosphatase Measurements

  1979cites this paper
• [Studies on estrogen in human male plasma. III. Plasma peptide and steroid hormone levels in patients with prostatic cancer and renal cell carcinoma (author's transl)].

  1979cites this paper
• Insulin-induced growth hormone responses in patients with prostatic carcinoma.

  1979cites this paper
• Chemical hypophysectomy for relief of bone pain in carcinoma of the prostate.

  1978cites this paper
• Human prostate steroid hormone receptor quantitation. Current methodology and possible utility as a clinical discriminant in carcinoma.

  1978cites this paper
• Treatment of advanced carcinoma of the prostate with estramustine phosphate.

  1977cites this paper
• Hypophysectomy in the treatment of disseminated prostate carcinoma

  1977cites this paper
• A critical analysis of tumor morphology and hormone treatments in the untreated and estrogen‐treated responsive and refractory human prostatic carcinoma

  1977cites this paper
• Steroid hormone receptors in the regulation of differentiation. A review.

  1977cites this paper
• Detection and diagnosis of prostate cancer.

  1976cites this paper
• Orchidectomy and immune response.

  1976cites this paper
• Carcinoma of the prostate: a focal point for divergent disciplines.

  1976cites this paper
• Regression of prostatic cancer metastasis by high doses of diethylstilbestrol diphosphate.

  1976cites this paper
• Prostate, Renal and Bladder Cancer

  1976cites this paper
• Comparative evaluation of serum acid phosphatase, urinary cholesterol, and androgens in diagnosis of prostatic cancer.

  1975cites this paper
• Management of reactivated prostatic cancer.

  1975cites this paper
• Hypophysectomy in metastatic breast cancer.

  1975cites this paper
• Current status of bilateral adrenalectomy or advanced prostatic carcinoma.

  1974cites this paper
• Adrenalectomy and hypophysectomy in disseminated prostatic cancer

  1974cites this paper
• Hypophysectomy in metastatic prostrate cancer.

  1974cites this paper
• Pharmacoclinical study of oral estramustine phosphate (Estracyt) in advanced carcinoma of the prostate.

  1974cites this paper
• Adrenal suppression in the treatment of carcinoma of the prostate.

  1974cites this paper
• Effects of inhibition of steroid biosynthesis on the lymphoid system.

  1974cites this paper
• Transvenous adrenal destruction: clinical trials in patients with metastatic malignancy.

  1974cites this paper
• Orchidectomy and the immune response. III. The effect of orchidectomy on tumour induction and transplantation in mice

  1974cites this paper
• Pituitary ablation and disseminated prostatic carcinoma.

  1973cites this paper
• Adrenalectomy and hypophysectomy for prostatic cancer.

  1973cites this paper
• Bilateral adrenalectomy for advanced prostatic carcinoma.

  1972cites this paper
• Adrenalectomy and hypophysectomy in advanced prostatic carcinoma

  1972cites this paper
• Bilateral adrenalectomy for palliative treatment of prostatic cancer.

  1972cites this paper